Paper Details
- Home
- Paper Details
[Pimecrolimus (Elidel) for therapy of lichen ruber mucosae].
Author: Kawari-MahmoodiN, KüblerA C, NeugebauerJ, ScheerM
Original Abstract of the Article :
Oral lichen planus (OLP) is a common chronic inflammatory disorder with criteria of auto-reactive disease. Treatment consists on topical application of corticosteroids, vitamin A derivates or cyclosporin. Calcineurin inhibitors as tacrolimus and pimecrolimus decrease the production of cytokines and ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s10006-006-0030-8
データ提供:米国国立医学図書館(NLM)
Pimecrolimus: A New Hope for Lichen Ruber Mucosae
Oral lichen planus (OLP), a chronic inflammatory condition affecting the mouth, can be a persistent and uncomfortable condition. This study investigates the effectiveness of pimecrolimus, a calcineurin inhibitor, in treating OLP. The researchers aimed to evaluate the effectiveness and safety of topical pimecrolimus compared to standard treatments like corticosteroids.
Pimecrolimus: A Potential Alternative for OLP Treatment
The study found that topical pimecrolimus was well-tolerated and effectively reduced inflammation in patients with OLP. While complete remission was not observed in this small study, the application of pimecrolimus significantly reduced symptoms like redness and burning sensations. However, the authors acknowledge the need for further research to compare pimecrolimus with standard treatments and to improve the cream's adherence properties for intra-oral application.
Finding Relief from Lichen Ruber Mucosae
This research provides a potential new treatment option for individuals suffering from OLP, offering hope for improved symptom management. While further research is necessary to fully evaluate its effectiveness and optimize its use, pimecrolimus shows promise as a potentially valuable treatment. It is important to consult with your doctor to discuss the best treatment options for your individual needs.
Dr. Camel's Conclusion
The desert of OLP can be a dry and uncomfortable place, but this research offers a refreshing glimpse of hope. Pimecrolimus provides a new avenue for treatment, potentially offering a more comfortable and manageable future for those affected by this condition. As with any new treatment, it is essential to discuss the potential benefits and risks with your doctor to determine if it is the right choice for you.
Date :
- Date Completed 2007-10-12
- Date Revised 2018-11-13
Further Info :
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.